Similar articles

• Clinical outcomes following institution of universal leukoreduction of blood transfusions for premature infants.

  Fergusson D, Hébert PC, Lee SK, Walker CR, Barrington KJ, Joseph L, Blajchman MA, Shapiro S. Fergusson D, et al. JAMA. 2003 Apr 16;289(15):1950-6. doi: 10.1001/jama.289.15.1950. JAMA. 2003. PMID: 12697797
• Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions.

  Hébert PC, Fergusson D, Blajchman MA, Wells GA, Kmetic A, Coyle D, Heddle N, Germain M, Goldman M, Toye B, Schweitzer I, vanWalraven C, Devine D, Sher GD; Leukoreduction Study Investigators. Hébert PC, et al. JAMA. 2003 Apr 16;289(15):1941-9. doi: 10.1001/jama.289.15.1941. JAMA. 2003. PMID: 12697796
• Evaluation of sampling procedures for quality monitoring of red cell concentrates: the need for improving sampling and sample handling techniques of red cell concentrate.

  Seghatchian MJ, Krailadsiri P, Sutherland J, Vasconcelos E, de Sousa G. Seghatchian MJ, et al. Transfus Sci. 1998 Dec;19(4):393-8. doi: 10.1016/s0955-3886(98)00077-0. Transfus Sci. 1998. PMID: 10351166 No abstract available.
• Quality of transfusion products in blood banking.

  Franchini M, Capuzzo E, Turdo R, Glingani C. Franchini M, et al. Semin Thromb Hemost. 2014 Mar;40(2):227-31. doi: 10.1055/s-0034-1365840. Epub 2014 Jan 28. Semin Thromb Hemost. 2014. PMID: 24474089 Review.
• [Therapy with cellular blood components].

  Eichler H, Klüter H. Eichler H, et al. Internist (Berl). 2001 May;42(5):760-8. doi: 10.1007/s001080050818. Internist (Berl). 2001. PMID: 11400584 Review. German. No abstract available.